Skip to Content
News & Insights

Category: Legal Updates

The After Final Consideration Pilot Program 2.0 (AFCP 2.0) has been a valuable tool for U.S. patent applicants since its inception in 2013. By offering […]

READ MORE
Cellect A Side: Two Courts Rely on In re Cellect to Reach Opposite Conclusions Regarding the Applicability of Obviousness-Type Double Patenting to Parent Applications

The Federal Circuit’s recent denial of Cellect’s en banc petition leaves for another day clarity with respect to the interplay between obviousness-type double patenting and […]

READ MORE
The Federal Circuit Affirms That Obviousness-type Double Patenting is Available for Patents Whose Expiration Dates Differ as a Result of Patent Term Adjustment

In Re: Cellect, LLC  Decided August 28, 2023 Nearly a decade ago, the Federal Circuit held that “the doctrine of obviousness-type double patenting continues to […]

READ MORE

Written description: a death knell to genus claims in biotechnology Brian M Gummow, Alison Care, Karen Mangasarian and James F Haley Jr Haley Guiliano LLP 18 August 2022 Shutterstock\Pixels […]

READ MORE

The Unified Patent Court finally looks like it will be up and running in Europe by the end of 2022 or in early 2023, after […]

READ MORE

A new referral made to the Enlarged Board of Appeal, G2/21, is expected to provide clarity and consistency on the issue of the use of […]

READ MORE

It has been nearly six months since the EPO updated the Guidelines for Examination at the European Patent Office (“the Guidelines”).   We take a look […]

READ MORE

Supplementary protection certificates (SPCs) allow for up to five and half years of additional patent protection for a medicinal product that has been authorised to […]

READ MORE

With the passing of the Trademark Modernization Act of 2020 (TMA), trademark stakeholders will need to familiarize themselves with changes to the Lanham Act, as […]

READ MORE

The end of the BREXIT transition period has no effect on European patents or patent applications. The European Patent Office (EPO) is European in name […]

READ MORE